George Torrejon

George Torrejon began their work experience as the Senior Director of Operations & Business Development at Glauconix Biosciences, Inc. in July 2016. George played a crucial role in utilizing bio-engineered human trabecular meshwork (HTM) technology for discovering glaucoma therapeutics.

In June 2017, Torrejon transitioned to the University at Albany, SUNY, where they worked as a Business Development Manager until May 2018.

Prior to that, Torrejon worked as an Internal Auditor at Broadridge Investment Accounting (Formerly QED Financial Systems) from March 2014 to May 2016.

From 2008 to 2013, George Torrejon attended the University at Albany, SUNY. During this time, they pursued a Bachelor of Science degree in Applied Economics.